Evidence map›Paper›PMID 35999696›Full record

ArticleEMBO reports2022

Evolutionary remodelling of N-terminal domain loops fine-tunes SARS-CoV-2 spike.

Diego Cantoni, Matthew J Murray, Mphatso D Kalemera, Samuel J Dicken, Lenka Stejskal, Georgina Brown, Spyros Lytras, Jonathon D Coey, James McKenna, Stephen Bridgett and 20 more

Abstract read
In one paragraph

Article in EMBO reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. A Pandemic-Scale Ancestral Recombination Graph for SARS-CoV-2.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Diego Cantoni *MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK.ORCID 0000-0001-8527-7719
Matthew J Murray *Division of Infection and Immunity, University College London, London, UK.ORCID 0000-0002-0379-7161
Mphatso D Kalemera *Division of Infection and Immunity, University College London, London, UK.ORCID 0000-0001-9461-1117
Samuel J Dicken *Division of Infection and Immunity, University College London, London, UK.ORCID 0000-0001-5663-1715
Lenka Stejskal *Division of Evolution, Infection and Genomics, University of Manchester, Manchester, UK.ORCID 0000-0002-4230-0963
Georgina BrownDivision of Infection and Immunity, University College London, London, UK.
Spyros LytrasMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK.ORCID 0000-0003-4202-6682
Jonathon D CoeyWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.ORCID 0000-0002-9697-2036
James McKennaBelfast Health and Social Care Trust, Belfast, UK.ORCID 0000-0003-4691-6711
Stephen BridgettBelfast Health and Social Care Trust, Belfast, UK.
David SimpsonWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Derek FairleyBelfast Health and Social Care Trust, Belfast, UK.
Lucy G ThorneDivision of Infection and Immunity, University College London, London, UK.ORCID 0000-0001-7358-6047
Ann-Kathrin ReuschlDivision of Infection and Immunity, University College London, London, UK.ORCID 0000-0002-1459-3519
Calum ForrestDivision of Infection and Immunity, University College London, London, UK.ORCID 0000-0002-0341-8547
Maaroothen GaneshalinghamDivision of Infection and Immunity, University College London, London, UK.
Luke MuirDivision of Infection and Immunity, University College London, London, UK.
Machaela PalorDivision of Infection and Immunity, University College London, London, UK.ORCID 0000-0003-4276-5346
Lisa JarvisScottish National Blood Transfusion Service, Glasgow, UK.ORCID 0000-0002-2842-1259
Brian WillettMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK.ORCID 0000-0001-8912-3266
Ultan F PowerWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.ORCID 0000-0003-3246-3774
Laura E McCoyDivision of Infection and Immunity, University College London, London, UK.ORCID 0000-0001-9503-7946
Clare JollyDivision of Infection and Immunity, University College London, London, UK.ORCID 0000-0002-4603-2281
Greg J TowersDivision of Infection and Immunity, University College London, London, UK.ORCID 0000-0002-7707-0264
Katie J DooresDepartment of Infectious Diseases, King's College London, London, UK.ORCID 0000-0002-5507-1725
David L RobertsonMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK.ORCID 0000-0001-6338-0221
Adrian J ShepherdDepartment of Biological Sciences, Birkbeck College London, London, UK.ORCID 0000-0003-0194-8613
Matthew B ReevesDivision of Infection and Immunity, University College London, London, UK.ORCID 0000-0002-4909-1076
Connor G G BamfordWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.ORCID 0000-0003-4895-1983
Joe GroveMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK.ORCID 0000-0001-5390-7579

Funding

Medical Research Council MC_PC_19026Medical Research Council MC_PC_19057Medical Research Council MC_UU_12014Medical Research Council MR/N013867/1Medical Research Council MR/R008698/1Medical Research Council MR/R021384/1Medical Research Council MR/S023380/1Medical Research Council MR/W005611/1Wellcome Trust 107653/Z/15/AWellcome Trust 108079/Z/15/ZWellcome Trust 204870/Z/16/ZWellcome Trust 223065
6 · The paper itself

Abstract

The emergence of SARS-CoV-2 variants has exacerbated the COVID-19 global health crisis. Thus far, all variants carry mutations in the spike glycoprotein, which is a critical determinant of viral transmission being responsible for attachment, receptor engagement and membrane fusion, and an important target of immunity. Variants frequently bear truncations of flexible loops in the N-terminal domain (NTD) of spike; the functional importance of these modifications has remained poorly characterised. We demonstrate that NTD deletions are important for efficient entry by the Alpha and Omicron variants and that this correlates with spike stability. Phylogenetic analysis reveals extensive NTD loop length polymorphisms across the sarbecoviruses, setting an evolutionary precedent for loop remodelling. Guided by these analyses, we demonstrate that variations in NTD loop length, alone, are sufficient to modulate virus entry. We propose that variations in NTD loop length act to fine-tune spike; this may provide a mechanism for SARS-CoV-2 to navigate a complex selection landscape encompassing optimisation of essential functionality, immune-driven antigenic variation and ongoing adaptation to a new host.

Indexed as

COVID-19SARS-CoV-2HumansPhylogenySpike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2NTDSARS-CoV-2spikevariants

Identifiers

PMID35999696
PMCPMC9535765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.